Relapses and Progression of Disability in Multiple Sclerosis

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis1998 · 2,061 citations
2. 2Multiple Sclerosis That Is Progressive From the Time of Onset1999 · 97 citations
3. 3Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis1995 · 1,896 citations
4. 4Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.1993 · 1,198 citations
5. 5Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up1993 · 571 citations